Sg3 Management, LLC Sio Gene Therapies Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $16,706 - $24,921	9,230 New	9,230 $20,000
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $72,450 - $101,150	-35,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.34 - $3.44 $29,250 - $43,000	12,500 Added 55.56%	35,000 $91,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $42,975 - $126,675	22,500 New	22,500 $63,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.